The Probability of Being in Response (PBR): A Novel Efficacy Endpoint for Chronic Graft Versus Host Disease (GvHD) Applied to the Reach-3 Study of Ruxolitinib Versus BAT

被引：0
|
作者：
Hollaender, Norbert [1 ]
Glimm, Ekkehard [1 ]
Gauvin, Jennifer [2 ]
Stefanelli, Tommaso [1 ]
Zeiser, Robert [3 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Univ Freiburg, Fac Med, Med Ctr, Dept Med 1, Freiburg, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10521 / 10522
页数：2
相关论文
共 50 条
  • [21] Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety
    Cheng, Chiao-Yu
    Lu, Meng-Yao
    Chang, Hsiu-Hao
    Yang, Yung-Li
    Wu, Chang-Hsueh
    Lin, Dong-Tsamn
    Lin, Kai-Hsin
    Chou, Shu-Wei
    Jou, Shiann-Tarng
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 753 - 760
  • [22] Oral ruxolitinib treatment for patients with ocular manifestations of chronic graft-versus-host disease: a post hoc analysis of the phase 3 REACH3 study
    Sunshine, Sarah
    Bhatt, Valkal
    Galvin, John
    Tian, Chuan
    Zieser, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] EFFICACY AND SAFETY OF RUXOLITINIB FOR PEDIATRIC ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE - A SINGLE CENTER EXPERIENCE
    Chou, Shu-Wei
    Lu, Meng-Yao
    Chang, Hsiu-Hao
    Yang, Yung-Li
    Jou, Shiann-Tarng
    BONE MARROW TRANSPLANTATION, 2024, 59 : 343 - 344
  • [24] Steroid refractory acute and chronic graft versus host disease (GVHD) -: Response to photophoresis±rituximab.
    Parameswaran, R
    Sekeramayi, M
    McCaul, K
    Bradfeldt, B
    BLOOD, 2005, 106 (11) : 425B - 425B
  • [25] RETROSPECTIVE MONOCENTRIC STUDY OF RUXOLITINIB COMPASSIONATE USE FOR ACUTE, CHRONIC AND OVERLAP GRAFT-VERSUS-HOST DISEASE (GVHD), INCLUDING GVHD AFTER INTERVENTIONAL DONOR LYMPHOCYTE INFUSION
    Loisl, Raphael
    Clausen, Johannes
    TRANSPLANT INTERNATIONAL, 2021, 34 : 33 - 33
  • [26] Early Versus Late Treatment with Ruxolitinib in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized, Phase 3 REACH3 Study
    Zeiser, Robert
    Xue, Zhenyi
    Bhatt, Valkal
    Galvin, John
    Locatelli, Franco
    BLOOD, 2022, 140 : 10507 - 10508
  • [27] EFFICACY AND SAFETY OF RUXOLITINIB IN THE TREATMENT OF CHRONIC REFRACTORY GRAFT VERSUS HOST DISEASE. EXPERIENCE IN 48 CONSECUTIVE PATIENTS
    Velao Sara, Redondo
    Sanfeliu Albert, Esquirol
    Canales Silvana, Novelli
    Ana Carolina, Caballero Gonzalez
    Diaz Ana, Garrido
    Pardo Jordi, Lopez
    Atanasio Carol, Moreno
    Silvanna Daniela, Saavedra Gerosa
    Gorrochategui Miquel, Granell
    Meijide Javier, Briones
    Gil Jordi, Sierra
    Irene, Garcia-Cadenas
    Bofarull Rodrigo, Martino
    HAEMATOLOGICA, 2021, 106 (10) : 276 - 277
  • [28] Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3)
    Zeiser, Robert
    Ram, Ron
    Foley, Stephen Ronan
    Yeshurun, Moshe
    Locatelli, Franco
    Artz, Andrew
    Gadbaw, Brian
    Atienza, Edric
    Hollaender, Norbert
    Delaite, Patricia
    Teshima, Takanori
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S208 - S208
  • [29] THE HOST RESPONSE IN GRAFT-VERSUS-HOST DISEASE .3. THE IN-VITRO INDUCTION OF REGULATORY CELLS IN CHRONIC MURINE GRAFT-VERSUS-HOST DISEASE
    MANN, RA
    SINGH, AB
    JETZT, AE
    SINGH, M
    CELLULAR IMMUNOLOGY, 1995, 164 (01) : 1 - 10
  • [30] Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study
    Gomez, Virginia Escamilla
    Gutierrez, Valentin Garcia
    Caballero-Velazquez, Teresa
    Rodriguez-Torres, Nancy
    Espigado, Ildefonso
    Corral, Lucia Lopez
    Caballero, Dolores
    Garcia-Cadenas, Irene
    Martino, Rodrigo
    Gerosa, Silvanna Daniela Saavedra
    Martinez, Ariadna Perez
    Sierra, Pedro Antonio Gonzalez
    Alegria, Maria De La Cruz Viguria
    Zudaire, Teresa
    Salinas, Ingrid Magnolia Parra
    Poch, Marc
    Vincent, Marta Gonzalez
    Perez, Miguel Angel Diaz
    Angulo, Blanca Molina
    Sanchez-Ortega, Isabel
    Porras, Rocio Parody
    Coll, Christelle M. Ferra
    Orti, Guillermo
    Valcarcel, David
    De La Camara, Rafael
    Moles, Paula
    Sanz, Jaime
    Gomez, Juan Montoro
    Velazquez-Kennedy, Kyra
    Perez-Simon, Jose A.
    BLOOD, 2017, 130
12345